Ryman Healthcare (NZE:RYM, ASX:RYM) reported Tuesday a fiscal 2026 net loss of NZ$0.169 per share, narrowing from a loss of NZ$0.724 in fiscal 2025.
Analysts polled by FactSet expected earnings of NZ$0.01.
Revenue for the year ended March 31 was NZ$855.6 million, up from NZ$760.7 million in the previous year.
Analysts surveyed by FactSet expected NZ$865.1 million.
The company said it expects fiscal 2027 capital expenditure of NZ$150 million to NZ$180 million, compared with NZ$221.8 million in fiscal 2026.